Variant report
Variant | esv12330 |
---|---|
Chromosome Location | chr11:6121495-6121968 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10839513 | chr11:6121496-6121497 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs34481020 | chr11:6121550-6121551 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs184219533 | chr11:6121554-6121555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546221047 | chr11:6121568-6121569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35349232 | chr11:6121572-6121573 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs5005636 | chr11:6121589-6121590 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs35938381 | chr11:6121601-6121602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188504918 | chr11:6121603-6121604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534058539 | chr11:6121604-6121605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150000439 | chr11:6121614-6121615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs5005637 | chr11:6121618-6121619 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs115190120 | chr11:6121626-6121627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs5005638 | chr11:6121633-6121634 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs5005639 | chr11:6121675-6121676 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs544708355 | chr11:6121731-6121732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559681032 | chr11:6121748-6121749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs5005640 | chr11:6121801-6121802 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs533401398 | chr11:6121814-6121815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181254933 | chr11:6121816-6121817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35515581 | chr11:6121820-6121821 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs5005642 | chr11:6121821-6121822 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs5005643 | chr11:6121865-6121866 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs5005644 | chr11:6121892-6121893 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs148040921 | chr11:6121916-6121917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186238000 | chr11:6121929-6121930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572625179 | chr11:6121946-6121947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141758599 | chr11:6121964-6121965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs6144194 | chr11:6121965-6121966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs386750252 | chr11:6121966-6121967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs200490266 | chr11:6121967-6121968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 19432969 | CNVD |
Alzheimer''s disease | 17576883 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Emphysema | 19352772 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Neuroblastoma | 21124317 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Schizophrenia | 21399695 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:6120400-6122000 | Enhancers | Primary T cells from cord blood | blood |
2 | chr11:6121000-6122000 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr11:6121200-6122000 | Enhancers | Monocytes-CD14+_RO01746 | blood |